SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 623,966 shares at $25.76 ($16.1M) on 2023-04-21, disclosed to the SEC on 2023-04-24.
Open-market sale of $16.1M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.06 | 6,590 | $165K | 1.0% |
| 2 | $25.06 | 6,590 | $165K | 1.0% |
| 3 | $25.76 | 289,485 | $7.5M | 46.4% |
| 4 | $25.76 | 289,485 | $7.5M | 46.4% |
| 5 | $26.01 | 15,908 | $414K | 2.6% |
| 6 | $26.01 | 15,908 |
| $414K |
| 2.6% |
| Total | $25.76 avg | 623,966 | $16.1M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |